Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 3/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.67 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.50 |
| ▸ | FDPS | P14324 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | KIF11 | P52732 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL8959000 | 0.98 | CYP2C9 (0.64) | CYP2C9CYP2C19CYP1A2KCNA5FDPS | |
| Diphenylmethanol SCHEMBL4184366 | 0.86 | CYP1A2 (0.52) | CYP2C9CYP2C19CYP1A2KCNA5FDPS | |
| SCHEMBL9987352 | 0.86 | CYP1A2 (0.52) | CYP2C9CYP2C19CYP1A2KCNA5FDPS | |
| SCHEMBL7020533 | 0.85 | CYP19A1 (0.56) | CYP2C9CYP2C19CYP1A2FDPSTSHR | |
| SCHEMBL7019811 | 0.85 | MEN1 (0.51) | CYP2C9CYP2C19CYP1A2FDPSSMN1; SMN2 | |
| SCHEMBL28446237 | 0.81 | CYP1A2 (0.50) | CYP2C9CYP2C19CYP1A2KCNA5FDPS | |
| SCHEMBL7025430 | 0.80 | LTA4H (0.53) | CYP2C9CYP2C19CYP1A2SMN1; SMN2LMNA | |
| SCHEMBL2854811 | 0.80 | CYP2C9 (0.67) | CYP2C9CYP2C19CYP1A2KCNA5FDPS | |
| SCHEMBL912792 | 0.80 | CYP2C9 (0.67) | CYP2C9CYP2C19CYP1A2KCNA5FDPS | |
| SCHEMBL28624141 | 0.80 | CYP2C9 (1.00) | CYP2C9CYP2C19CYP1A2KCNA5FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 336 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3604316-B1 | SYNTHESIS OF BORONATE SALTS | MELINTA THERAPEUTICS INC (US) | 2023-12-06 | — | — | EP | claimed |
| CN-115197064-A | Workability adjusting functional monomer for producing polycarboxylate superplasticizer mother liquor | 烟台大学 | 2022-10-18 | — | — | CN | claimed |
| CN-113024488-A | Glycidyl ether product of monophenol or polyphenol, preparation method thereof and epoxy resin composition | 长春人造树脂厂股份有限公司 | 2021-06-25 | — | — | CN | claimed |
| US-10669292-B2 | Synthesis of boronate salts and uses thereof | REMPEX PHARMACEUTICALS, INC. (US) | 2020-06-02 | — | — | US | claimed |
| EP-3604316-A1 | SYNTHESIS OF BORONATE SALTS | Rempex Pharmaceuticals, Inc. (US) | 2020-02-05 | — | — | EP | claimed |
| US-20200031851-A1 | SYNTHESIS OF BORONATE SALTS AND USES THEREOF | MELINTA SUBSIDIARY CORP. | 2020-01-30 | — | — | US | claimed |
| US-5391802-A | Process for cleaving polycarbonates into bisphenols and diaryl carbonates | BAYER AKTIENGESELLSCHAFT (DE) | 1995-02-21 | — | — | US | claimed |
| EP-0359037-A2 | Low-viscosity polyamide mouldings and mixtures | BAYER AG (DE) | 1990-03-21 | — | — | EP | claimed |
| US-4154969-A | FROM DIBROMOETHANE AND PHENOL, WITH ZINC OXIDE AND ZINC OXIDE CATALYST | MONSANTO COMPANY (US) | 1979-05-15 | — | — | US | claimed |
| US-4091038-A | IODINE AS PROMOTER, PHENOL AND 1,2-DIHALOETHANE, ZINC CONTAINING CATALYST | MONSANTO COMPANY (US) | 1978-05-23 | — | — | US | claimed |
| JP-10310692-A | — | — | None | — | — | JP | disclosed |
| JP-6345789-A | — | — | None | — | — | JP | disclosed |
| JP-5051452-A | — | — | None | — | — | JP | disclosed |
| EP-4381345-B1 | SWITCHING LAYERS FOR USE IN A WINDOW ELEMENT | MERCK PATENT GMBH (DE) | 2026-05-27 | — | — | EP | disclosed |
| US-12595415-B2 | Aromatic isothiocyanates | MERCK PATENT GMBH (DE) | 2026-04-07 | — | — | US | disclosed |
| US-4154969-A | FROM DIBROMOETHANE AND PHENOL, WITH ZINC OXIDE AND ZINC OXIDE CATALYST | MONSANTO COMPANY (US) | 1979-05-15 | — | — | US | disclosed |
| US-4110542-A | ALKYLATION OF PHENOL WITH 1,2-DIHALOETHANE, LANTHANUM OXIDE SUPPORTED CATALYST | MONSANTO COMPANY (US) | 1978-08-29 | — | — | US | disclosed |
| US-4091038-A | IODINE AS PROMOTER, PHENOL AND 1,2-DIHALOETHANE, ZINC CONTAINING CATALYST | MONSANTO COMPANY (US) | 1978-05-23 | — | — | US | disclosed |
| US-4091038-A | IODINE AS PROMOTER, PHENOL AND 1,2-DIHALOETHANE, ZINC CONTAINING CATALYST | MONSANTO COMPANY (US) | 1978-05-23 | — | — | US | disclosed |
| US-3931449-A | Resinous laminates having improved gas permeation and resistance to delamination | TOYO SEIKAN KAISHA LIMITED (JA) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200031851-A1 | SYNTHESIS OF BORONATE SALTS AND USES THEREOF | BTD, BCL6B, BRI3BP | CYP2C9 1455/4885CYP2C19 1386/4885CYP1A2 1681/4885 |
| US-12595415-B2 | Aromatic isothiocyanates | NAF1, H1-0, HNRNPU | CYP2C9 4228/4885CYP2C19 4625/4885CYP1A2 3807/4885 |
| US-10669292-B2 | Synthesis of boronate salts and uses thereof | BTD, BCL6B, BRI3BP | CYP2C9 1455/4885CYP2C19 1386/4885CYP1A2 1681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.